Skip to main content

8-K

Proto Labs Inc (PRLB)

8-K 2023-08-04 For: 2023-08-04
View Original
Added on April 12, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 4, 2023

Proto Labs, Inc.

(Exact name of registrant as specified in its charter)

Minnesota 001-35435 41-1939628
(State or other jurisdiction<br>of incorporation) (Commission File Number) (IRS Employer<br>Identification Number) 5540 Pioneer Creek Drive<br><br>Maple Plain, Minnesota 55359
--- ---
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (763) 479-3680 Not Applicable
---
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On August 4, 2023, Proto Labs, Inc. issued a press release announcing its second quarter 2023 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

99.1 Press release of Proto Labs, Inc. datedAugustprlb-20230804xexx991.htm4, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Proto Labs, Inc.
Date: August 4, 2023 By: /s/ Daniel Schumacher
Daniel Schumacher
Chief Financial Officer

Document

Exhibit 99.1

Protolabs Reports Financial Results for the Second Quarter of 2023

Revenue of $122.3 million in the Second Quarter of 2023

Network revenue of $20.2 million; a 79.3% YoY increase

GAAP Loss Per Share of $0.01; Non-GAAP Earnings Per Share of $0.33

MAPLE PLAIN, Minn. – August 4, 2023 – Proto Labs, Inc. (the "Company" or "Protolabs") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the second quarter ended June 30, 2023.

Second Quarter 2023 Highlights:

•Revenue for the second quarter of 2023 was $122.3 million, representing a 3.7 percent decrease compared to revenue of $126.9 million in the second quarter of 2022.

•Revenue generated from our digital network powered by Hubs was $20.2 million in the second quarter, representing growth of 79.3 percent over the second quarter of 2022 and 17.6 percent sequential growth compared to the first quarter of 2023.

•Net loss for the second quarter of 2023 was $0.4 million, or $0.01 per diluted share.

•Non-GAAP net income was $8.7 million, or $0.33 per diluted share. See “Non-GAAP Financial Measures” below.

“Our broad customer offer, powered by internal digital factories and network manufacturing partners, allows us to offer customers a differentiated value proposition and serve their varying needs in any economic climate,” said Rob Bodor, President and Chief Executive Officer. “Amidst the continued contraction of manufacturing, Protolabs improved gross and operating margins sequentially while continuing to delight our customers and advance our 2023 strategic initiatives.”

Additional Second Quarter 2023 Highlights:

•Protolabs served 23,377 unique product developers during the quarter.

•The Company repurchased $9.0 million of shares during the quarter.

•Gross margin was 43.4 percent of revenue in the second quarter of 2023.

•Non-GAAP gross margin was 44.1 percent of revenue in the second quarter of 2023, representing a sequential increase of 70 basis points. See “Non-GAAP Financial Measures” below.

•EBITDA was $11.4 million, or 9.3 percent of revenue, in the second quarter of 2023, compared to $15.1 million, or 11.9 percent of revenue, in the second quarter of 2022. See “Non-GAAP Financial Measures” below.

•Adjusted EBITDA was $19.2 million, or 15.7% of revenue, in the second quarter of 2023, compared to $24.6 million, or 19.4% of revenue, in the second quarter of 2022. See “Non-GAAP Financial Measures” below.

•Cash and investments balance was $102.8 million as of June 30, 2023.

“Driven by the current economic climate, through the first half of 2023 demand for our longer lead times and lower-priced offerings has outpaced demand for our quick-turn offer, and we will continue to adapt our operations to align with demand,” said Dan Schumacher, Chief Financial Officer. “We are among the most profitable and positive cash generating digital manufacturers, enabling us to continue to invest in future growth among economic volatility and dynamic customer preferences.”

Non-GAAP Financial Measures

The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”). Management believes these metrics, when

viewed in conjunction with the comparable GAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.

The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency and costs related to the Japan closure activities (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency and costs related to the Japan closure activities (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense and costs related to the closure of Japan (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP gross margin excluding Japan, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the Company’s financial results. The Company has included non-GAAP operating margin excluding Japan, adjusted for stock-based compensation expense, amortization expense, and costs related to the Japan closure activities (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and costs related to the closure of Japan (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.

The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP gross margin, non-GAAP gross margin excluding Japan, non-GAAP operating margin, non-GAAP operating margin excluding Japan, non-GAAP revenue growth by region and by service, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the Company’s business. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

Conference Call

The Company has scheduled a conference call to discuss its second quarter 2023 financial results and third quarter 2023 outlook today, August 4, 2023 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/ik5odgi6. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

About Protolabs

Protolabs is the fastest and most comprehensive digital manufacturing service in the world. Our digital factories produce low-volume parts in days while our digital network of manufacturing partners powered by Hubs unlocks advanced capabilities and volume pricing at higher quantities. The result? One manufacturing source—from prototyping to production—for product developers, engineers, and supply chain teams across the globe. See what's next at protolabs.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than

those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

Source: Proto Labs, Inc.

Investor Relations Contact

Protolabs

Ryan Johnsrud, 612-225-4873

Manager – Investor Relations and FP&A

ryan.johnsrud@protolabs.com

Media Contact

Protolabs

Brent Renneke, 763-479-7704

PR & Media Strategist

brent.renneke@protolabs.com

Proto Labs, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

June 30,<br>2023 December 31,<br>2022
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 66,493 $ 56,558
Short-term marketable securities 19,945 23,568
Accounts receivable, net 75,034 76,225
Inventory 14,311 13,578
Income taxes receivable 868 4,042
Prepaid expenses and other current assets 8,501 12,597
Total current assets 185,152 186,568
Property and equipment, net 248,614 257,785
Goodwill 273,991 273,991
Other intangible assets, net 28,353 31,250
Long-term marketable securities 16,344 26,419
Operating lease assets 3,084 3,844
Finance lease assets 16,934 17,532
Other long-term assets 4,738 4,779
Total assets $ 777,210 $ 802,168
Liabilities and shareholders' equity
Current liabilities
Accounts payable $ 16,474 $ 17,356
Accrued compensation 12,486 12,743
Accrued liabilities and other 19,155 22,384
Current operating lease liabilities 1,209 1,561
Current finance lease liabilities 16,549 17,537
Income taxes payable 348
Total current liabilities 66,221 71,581
Long-term operating lease liabilities 1,833 2,255
Long-term finance lease liabilities 745
Long-term deferred tax liabilities 20,790 26,322
Other long-term liabilities 4,936 4,362
Shareholders' equity 682,685 697,648
Total liabilities and shareholders' equity $ 777,210 $ 802,168

Proto Labs, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share amounts)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Revenue
Injection Molding $ 48,819 $ 53,355 $ 100,767 $ 106,753
CNC Machining 48,297 48,222 96,401 94,320
3D Printing 21,005 19,963 42,330 39,635
Sheet Metal 3,939 5,160 8,187 9,847
Other Revenue 205 202 439 515
Total Revenue 122,265 126,902 248,124 251,070
Cost of revenue 69,142 69,480 141,225 137,844
Gross profit 53,123 57,422 106,899 113,226
Operating expenses
Marketing and sales 21,730 21,055 44,181 41,641
Research and development 9,865 9,450 20,542 20,007
General and administrative 15,822 16,522 32,655 33,293
Closure of Japan business 98 5,194 164 5,194
Total operating expenses 47,515 52,221 97,542 100,135
Income from operations 5,608 5,201 9,357 13,091
Other (loss) income, net (3,368) 1 (2,078) (299)
Income before income taxes 2,240 5,202 7,279 12,792
Provision for income taxes 2,623 2,645 5,003 5,140
Net (loss) income $ (383) $ 2,557 $ 2,276 $ 7,652
Net (loss) income per share:
Basic $ (0.01) $ 0.09 $ 0.09 $ 0.28
Diluted $ (0.01) $ 0.09 $ 0.09 $ 0.28
Shares used to compute net (loss) income per share:
Basic 26,210,478 27,530,739 26,414,467 27,515,583
Diluted 26,210,478 27,536,823 26,445,427 27,524,019

Proto Labs, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Six Months Ended<br>June 30,
2023 2022
Operating activities
Net income $ 2,276 $ 7,652
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 18,883 20,274
Stock-based compensation expense 7,370 8,428
Deferred taxes (5,605) (5,653)
Interest on finance lease obligations 568 -
Loss on foreign currency translation 3,906 -
Impairments related to closure of Japan business - 1,792
Gain on disposal of property and equipment (428) -
Other 215 32
Changes in operating assets and liabilities: 4,682 (1,485)
Net cash provided by operating activities 31,867 31,040
Investing activities
Purchases of property, equipment and other capital assets (6,829) (6,030)
Proceeds from sales of property, equipment and other capital assets 623 -
Purchases of marketable securities - (38,882)
Proceeds from sales of marketable securities 1,000
Proceeds from call redemptions and maturities of marketable securities 14,020 7,396
Net cash provided by (used in) investing activities 7,814 (36,516)
Financing activities
Proceeds from exercises of stock options 1,986 2,311
Purchases of shares withheld for tax obligations (1,425) (1,615)
Repurchases of common stock (30,064) (5,239)
Principal repayments of finance lease obligations (163) (278)
Net cash used in financing activities (29,666) (4,821)
Effect of exchange rate changes on cash and cash equivalents (80) (966)
Net increase (decrease) in cash and cash equivalents 9,935 (11,263)
Cash and cash equivalents, beginning of period 56,558 65,929
Cash and cash equivalents, end of period $ 66,493 $ 54,666

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Net Income per Share

(In thousands, except share and per share amounts)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and costs related to Japan closure activities
GAAP net (loss) income $ (383) $ 2,557 $ 2,276 $ 7,652
Add back:
Stock-based compensation expense 3,675 4,031 7,370 8,428
Amortization expense 1,484 1,527 3,010 3,072
Unrealized (gain) loss on foreign currency 187 271 115 360
Costs related to Japan closure activities 4,004 5,194 4,070 5,194
Total adjustments 1 9,350 11,023 14,565 17,054
Income tax benefits on adjustments 2 (296) (776) (298) (1,458)
Non-GAAP net income $ 8,671 $ 12,804 $ 16,543 $ 23,248
Non-GAAP net income per share:
Basic $ 0.33 $ 0.47 $ 0.63 $ 0.84
Diluted $ 0.33 $ 0.46 $ 0.63 $ 0.84
Shares used to compute non-GAAP net income per share:
Basic 26,210,478 27,530,739 26,414,467 27,515,583
Diluted 26,224,562 27,536,823 26,445,427 27,524,019

1Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and costs related to Japan closure activities were included in the following GAAP consolidated statement of operations categories:

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Cost of revenue $ 803 $ 870 $ 1,611 $ 1,799
Marketing and sales 855 813 1,547 1,550
Research and development 641 471 1,212 1,100
General and administrative 2,861 3,404 6,010 7,051
Closure of Japan business 98 5,194 164 5,194
Total operating expenses 4,455 9,882 8,933 14,895
Other income (loss), net 4,092 271 4,021 360
Total adjustments $ 9,350 $ 11,023 $ 14,565 $ 17,054

2For the three and six months ended June 30, 2023 and 2022, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Gross Margin

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Revenue $ 122,265 $ 126,902 $ 248,124 $ 251,070
Gross profit 53,123 57,422 106,899 113,226
GAAP gross margin 43.4 % 45.2 % 43.1 % 45.1 %
Add back:
Stock-based compensation expense 461 528 927 1,115
Amortization expense 342 342 684 684
Total adjustments 803 870 1,611 1,799
Non-GAAP gross profit $ 53,926 $ 58,292 $ 108,510 $ 115,025
Non-GAAP gross margin 44.1 % 45.9 % 43.7 % 45.8 %

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Gross Margin Excluding Japan

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Revenue $ 122,265 $ 126,902 $ 248,124 $ 251,070
Revenue excluding Japan $ 122,265 $ 124,046 $ 248,124 $ 244,128
Gross profit 53,123 57,422 106,899 113,226
GAAP gross margin 43.4 % 45.2 % 43.1 % 45.1 %
Less: Japan gross profit - 1,063 - 3,102
Gross Profit excluding Japan 53,123 56,359 106,899 110,124
GAAP gross margin excluding Japan 43.4 % 45.4 % 43.1 % 45.1 %
Add back:
Stock-based compensation expense 461 528 927 1,115
Amortization expense 342 342 684 684
Less:
Japan stock-based compensation expense - 22 - 47
Japan amortization expense - - - -
Total adjustments 803 848 1,611 1,752
Non-GAAP gross profit excluding Japan $ 53,926 $ 57,207 $ 108,510 $ 111,876
Non-GAAP gross margin excluding Japan 44.1 % 46.1 % 43.7 % 45.8 %

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Revenue $ 122,265 $ 126,902 $ 248,124 $ 251,070
Income from operations 5,608 5,201 9,357 13,091
GAAP operating margin 4.6 % 4.1 % 3.8 % 5.2 %
Add back:
Stock-based compensation expense 3,675 4,031 7,370 8,428
Amortization expense 1,484 1,527 3,010 3,072
Costs related to Japan closure activities 98 5,194 164 5,194
Total adjustments 5,257 10,752 10,544 16,694
Non-GAAP income from operations $ 10,865 $ 15,953 $ 19,901 $ 29,785
Non-GAAP operating margin 8.9 % 12.6 % 8.0 % 11.9 %

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin Excluding Japan

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Revenue $ 122,265 $ 126,902 $ 248,124 $ 251,070
Revenue excluding Japan $ 122,265 $ 124,046 $ 248,124 $ 244,128
Income from operations 5,608 5,201 9,357 13,091
GAAP operating margin 4.6 % 4.1 % 3.8 % 5.2 %
Less: Japan (loss) income from operations (128) (542) (474) 4
Income from operations excluding Japan 5,736 5,743 9,831 13,087
GAAP operating margin excluding Japan 4.7 % 4.6 % 4.0 % 5.4 %
Add back:
Stock-based compensation expense 3,675 4,031 7,370 8,428
Amortization expense 1,484 1,527 3,010 3,072
Costs related to Japan closure activities 98 5,194 164 5,194
Less:
Japan stock-based compensation expense 7 147 17 297
Japan amortization expense - - - -
Total adjustments 5,250 10,605 10,527 16,397
Non-GAAP income from operations excluding Japan $ 10,986 $ 16,348 $ 20,358 $ 29,484
Non-GAAP operating margin excluding Japan 9.0 % 13.2 % 8.2 % 12.1 %

Proto Labs, Inc.

Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, Six Months Ended<br>June 30,
2023 2022 2023 2022
Revenue $ 122,265 $ 126,902 $ 248,124 $ 251,070
GAAP net (loss) income (383) 2,557 2,276 7,652
GAAP net (loss) income margin (0.3 %) 2.0 % 0.9 % 3.0 %
Add back:
Amortization expense $ 1,484 $ 1,527 $ 3,010 $ 3,072
Depreciation expense 8,011 8,515 15,873 17,202
Interest income, net (372) (149) (722) (194)
Provision for income taxes 2,623 2,645 5,003 5,140
EBITDA 11,363 15,095 25,440 32,872
EBITDA Margin 9.3 % 11.9 % 10.3 % 13.1 %
Add back:
Stock-based compensation expense 3,675 4,031 7,370 8,428
Unrealized (gain) loss on foreign currency 187 271 115 360
Costs related to Japan closure activities 4,004 5,194 4,070 5,194
Total adjustments 7,866 9,496 11,555 13,982
Adjusted EBITDA $ 19,229 $ 24,591 $ 36,995 $ 46,854
Adjusted EBITDA Margin 15.7 % 19.4 % 14.9 % 18.7 %

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth by Region

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, 2023 Three Months Ended June 30, 2022 %<br><br>Change2 % Change<br><br>Organic3
GAAP Foreign<br><br>Currency1 Non-GAAP GAAP
Revenues
United States $ 96,321 $ - $ 96,321 $ 100,655 (4.3 %) (4.3 %)
Europe 25,944 512 26,456 23,391 10.9 % 13.1 %
Japan - - - 2,856 (100.0 %) (100.0 %)
Total revenue $ 122,265 $ 512 $ 122,777 $ 126,902 (3.7 %) (3.3 %) Six Months Ended<br>June 30, 2023 Six Months Ended June 30, 2022 %<br><br>Change2 % Change<br><br>Organic3
--- --- --- --- --- --- --- --- --- --- --- --- ---
GAAP Foreign<br><br>Currency1 Non-GAAP GAAP
Revenues
United States $ 194,067 $ - $ 194,067 $ 196,151 (1.1 %) (1.1 %)
Europe 54,057 2,977 57,034 47,977 12.7 % 18.9 %
Japan - - - 6,942 (100.0 %) (100.0 %)
Total revenue $ 248,124 $ 2,977 $ 251,101 $ 251,070 (1.2 %) %

1Revenue for the three and six months ended June 30, 2023 has been recalculated using 2022 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

2This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2022 to GAAP revenue for the three and six months ended June 30, 2023.

3This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2022 to non-GAAP revenue for the three and six months ended June 30, 2023 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2022) in order to provide a constant-currency comparison.

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth by Service Line

(In thousands)

(Unaudited)

Three Months Ended<br>June 30, 2023 Three Months Ended June 30, 2022 %<br><br>Change2 % Change<br><br>Organic3
GAAP Foreign<br><br>Currency1 Non-GAAP GAAP
Revenues
Injection Molding $ 48,819 $ 257 $ 49,076 $ 53,355 (8.5) % (8.0) %
CNC Machining 48,297 125 48,422 48,222 0.2 0.4
3D Printing 21,005 131 21,136 19,963 5.2 5.9
Sheet Metal 3,939 1 3,940 5,160 (23.7) (23.6)
Other Revenue 205 (2) 203 202 1.5 0.5
Total Revenue $ 122,265 $ 512 $ 122,777 $ 126,902 (3.7 %) (3.3 %)
Six Months Ended<br>June 30, 2023 Six Months Ended June 30, 2022 %<br><br>Change2 % Change<br><br>Organic3
--- --- --- --- --- --- --- --- --- --- --- --- ---
GAAP Foreign<br><br>Currency1 Non-GAAP GAAP
Revenues
Injection Molding $ 100,767 $ 1,436 $ 102,203 $ 106,753 (5.6) % (4.3) %
CNC Machining 96,401 860 97,261 94,320 2.2 3.1
3D Printing 42,330 667 42,997 39,635 6.8 8.5
Sheet Metal 8,187 11 8,198 9,847 (16.9) (16.7)
Other Revenue 439 3 442 515 (14.8) (14.2)
Total Revenue $ 248,124 $ 2,977 $ 251,101 $ 251,070 (1.2 %) %

1Revenue for the three and six months ended June 30, 2023 has been recalculated using 2022 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

2This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2022 to GAAP revenue for the three and six months ended June 30, 2023.

3This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2022 to non-GAAP revenue for the three and six months ended June 30, 2023 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2022) in order to provide a constant-currency comparison.

Proto Labs, Inc.

Product Developer Information

(Unaudited)

Three months ended June 30, Six months ended June 30,
2023 2022 2023 2022
Unique product developers and engineers served 23,377 24,058 35,743 36,878